Please login to the form below

Not currently logged in
Email:
Password:

Ultibro Breezhaler

This page shows the latest Ultibro Breezhaler news and features for those working in and with pharma, biotech and healthcare.

Novartis signs 'connected inhaler' deal with Propeller Health

Novartis signs 'connected inhaler' deal with Propeller Health

Novartis signs 'connected inhaler' deal with Propeller Health. Will connect its Breezhaler devices to Propeller's digital platform. ... The inhaler is currently used as part of Novartis' Ultibro Breezhaler, Onbrez Breezhaler and Seebri Breezhaler COPD

Latest news

  • Vectura to merge with SkyePharma in £441m deal Vectura to merge with SkyePharma in £441m deal

    Vectura recorded revenues of £26m in the six-month period ended September 2015 - up 35% - as royalties increased on products such as Novartis' Ultibro Breezhaler (indacaterol/glycopyrronium bromide).

  • Novartis sets sights on connected inhaler Novartis sets sights on connected inhaler

    The next-generation Breezhaler falls within the pharma firm's collaboration with Qualcomm, whose Qualcomm Life subsidiary provides wireless solutions for the management of chronic diseases and sharing of medical information. ... Novartis plans a 2019

  • Novartis' combo COPD inhaler cleared in EU Novartis' combo COPD inhaler cleared in EU

    Novartis' Ultibro Breezhaler has become the first dual action bronchodilator to be approved in the EU for chronic obstructive pulmonary disease (COPD). ... Many COPD patients will now have a better treatment option, including first-line therapy with the

  • Boehringer’s first cancer drug leads EMA recommendations Boehringer’s first cancer drug leads EMA recommendations

    Novartis COPD inhaler recommended in EU. Elsewhere among the CHMP's recommendations, Novartis received backing for the Ultibro Breezhaler as a once-daily maintenance treatment to relive symptoms in adults with ... The product, which is to be marketed as

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics